Tate & Lyle serves up first-quarter profit decline
24th Jul 2014 09:45
Sweetener specialist Tate & Lyle on Thursday admitted its operating profit for the first quarter had come in below expectations as the group continued to suffer the effects of the severe US winter, the temporary closure of its Splenda Sucralose facility in Singapore and the strength of sterling. O
Read moreFTSE 250 movers: Hochschild lifted by rating, Bellway falls
21st Jul 2014 15:32
Housebuilder Bellway was lower amid a wider sector decline after Rightmove published data that showed the average asking price for a UK home dropped 0.8% from £272,275 in June to £270,159 in July. The also had its 'hold' rating reiterated by Deutsche Bank. Oil stocks including Cairn Energy weake
Read moreTate & Lyle poaches CFO from PepsiCo
24th Jun 2014 09:04
Sugar and ingredients group Tate & Lyle has appointed a new Chief Financial Officer (CFO) poached from PepsiCo. Current CFO Tim Lodge, who has been in the role since 2008, will step down at the end of August, with new man Nick Hampton taking up the role on September 1st and working with Lodge for a
Read moreTate & Lyle divisional head pockets half a million on share sale
20th Jun 2014 16:10
Tate & Lyle's President of speciality food ingredients has sold 74,588 shares in the sugar and sweetener giant after the shares were released under the group's performance share plan. Olivier Rigaud, who took up his current role at the sugars and sweeteners group in June 2010, traded the shares in
Read moreThursday broker round-up UPDATE
5th Jun 2014 09:37
Aberdeen Asset Management: Liberum Capital initiates with a target price of 555p and a buy recommendation. Ashmore Group: Liberum Capital starts with a target price of 303p and a sell recommendation. ASOS: N+1 Singer places both its target price (prev.: 4100p) and its hold recommendation under rev
Read moreBroker tips: Shire, Foxtons, Tate & Lyle, Bowleven
3rd Jun 2014 12:46
UBS has hiked its target price for Shire by nearly a tenth, saying that the rumoured acquisition of Nasdaq-listed NPS Pharmaceuticals would "make sense" for the Dublin-based biopharmaceutical group. The bank kept a 'neutral' stance on the shares, but lifted its target from 3,150p to 3,450p. UBS sai
Read moreJPMorgan upbeat about sustainable profit growth at Tate & Lyle
3rd Jun 2014 11:14
In spite of a tough year ahead of Tate & Lyle, JPMorgan Cazenove has reiterated its 'overweight' recommendation for the sugar and sweeteners manufacturer, saying that the business is "focused, fixed and ready for growth". The bank has trimmed its profit forecasts for the company for the current fin
Read moreFTSE 250 movers: Fenner plunges following profit warning
30th May 2014 14:21
Polymer products maker Fenner slumped after warning that underlying group profit before tax for the current fiscal year could be reduced by as much as 10-15% below the current consensus market expectation of £77.6m. This was partly due to what are expected to be "significantly weaker" than previou
Read moreCredit Suisse downgrades Tate & Lyle to 'underperform'
30th May 2014 11:02
Credit Suisse has lowered its recommendation for Tate & Lyle from 'neutral' to 'underperform' after a "slow start to the year" for the sugar and sweeteners group. The bank said that despite the improvement seen at the business there is "little/no earnings growth". Meanwhile, Tate is also facing a
Read moreFriday broker round-up UPDATE
30th May 2014 09:14
ASOS: N+1 Singer reduces target price from 5300p to 4100p, while staying with its hold recommendation. Cairn Energy: JP Morgan cuts target price from 315p to 279p and maintains an overweight rating. Cobham: Canaccord Genuity increases target price from 285p to 320p and reiterates a hold recommenda
Read moreFTSE 250 movers: Man climbs after confirming M&A talks
29th May 2014 14:59
Man Group leapt after it confirmed it is in talks to buy US money manager Numeric Holdings. The world's largest publicly traded hedge-fund manager said the discussions are "ongoing and may or may not lead to a transaction". Numeric, which uses quantitative analysis to make investments, manages $13.9
Read moreTate & Lyle in line but warns of slow start to new year
29th May 2014 08:06
- Earnings down 2% but ahead of consensus at 55.7p - Final dividend up 5.3% to 19.8p - For 2015, sucralose headwinds expected - For 2015, slow start expected for Bulk Ingredients In the face of tough competition in artificial sweeteners and adverse weather effects, Tate & Lyle produced annual reve
Read moreLondon close: Investors ponder merits of TSB float
27th May 2014 16:58
- FTSE 100 catches up after long weekend - Euroscepticism tempered by election results in Italy, Greece - IHG gains on bid interest - Lloyds to float TSB division - Pfizer walks away from AstraZeneca proposal techMARK 2,786.31 +1.03% FTSE 100 6,844.94 +0.43% FTSE 250 15,843.93 +0.88% Equities ende
Read moreFTSE 250 movers: AVEVA and Greencore rise on broker comments
27th May 2014 16:09
Software maker AVEVA revealed an 11 per cent increase in full-year profit underpinned by strong demand at its Engineering and Design Systems unit and improved margins. Following the results analysts at Numis Securities reiterated their 'buy' recommendation on the shares, saying they are significantl
Read moreBroker tips: BG Group, Tate & Lyle, SABMiller, AVEVA
27th May 2014 12:57
Kepler Cheuvreux has lowered its recommendation for BG Group from 'hold' to 'reduce', saying that prevailing uncertainties are clouding the outlook for the oil and gas firm. Analyst Peter Oppitzhauser said that BG's upstream portfolio "comes with high project delivery risk (high concentration risk,
Read more